Global Sepsis Diagnostics Market Size & Trends Report Segmented by Product (Instruments, Reagents, Assays, Blood Culture Media, Software), Technology (Microbiology Testing, Molecular Diagnostics, Immunoassays, Microfluidics), Pathogen Type (Bacterial, Fungal, Viral) & Regional Forecast to 2030

Request Quote Download FREE Sample
Single User

Table of Contents

1.      Introduction

1.1.    Introduction

1.2.    Market Scope

1.2.1        Market Definition

1.2.2        Segments Covered

1.2.3        Regional Segmentation

1.3.    Research Timeframe

1.4.    Currency Considered

1.5.    Study Limitations

1.6.    Stakeholders

1.7.    List of Abbreviations

1.8.    Key Conferences and Events (2025-2026)

2.      Research Methodology

2.1.    Secondary Research

2.2.    Primary Research

2.3.    Market Estimation

2.3.1         Bottom-Up Approach

2.3.2         Top-Down Approach

2.4.    Market Forecasting

3.      Executive Summary

3.1.    Sepsis Diagnostics Market Snapshot (2025-2030)

3.2.    Segment Overview

3.3.    Regional Snapshot

3.4.    Competitive Insights  

4.      Market Overview

4.1.    Market Dynamics

4.1.1.   Drivers

4.1.1.1.  High incidence of sepsis cases globally

4.1.1.2.  Increasing use of biomarker and molecular tools

4.1.1.3.  Government initiatives and growing sepsis awareness

4.1.1.4.  Rising demand for point-of-care (POC) testing  

4.1.2.   Restraints

4.1.2.1.  Costs & infrastructure barriers

4.1.2.2.  Limited availability of diagnostics and trained staff

4.1.2.3.  Clinical complexity of sepsis

4.1.3.  Opportunities

4.1.3.1.  Emerging & underserved markets

4.1.3.2.  Novel biomarkers & multiplex panels

4.1.3.3.  Digital biomarkers  

4.2.    Key Market Trends

4.2.1.  Emphasis on hospital-acquired infection (HAI) detection

4.2.2.  Adoption of molecular diagnostics

4.3.    Unmet Market Needs

4.4.    Industry Speaks

5.      Global Sepsis Diagnostics Market Size & Forecast (2023-2030), By Product, USD Million

5.1.    Introduction

5.2.    Instruments

5.3.    Reagents & Assays

5.4.    Blood Culture Media

5.5.    Software & Platforms

6.      Global Sepsis Diagnostics Market Size & Forecast (2023-2030), By Technology, USD Million

6.1.    Introduction

6.2.    Microbiology Testing

6.3.    Molecular Diagnostics

6.4.    Immunoassays

6.5.    Flow Cytometry

6.6.    Microfluidics

6.7.    Others

7.      Global Sepsis Diagnostics Market Size & Forecast (2023-2030), By Pathogen Type, USD Million

7.1.    Introduction

7.2.    Bacterial Sepsis

7.3.    Fungal Sepsis

7.4.    Viral Sepsis

7.5.    Others

8.      Global Sepsis Diagnostics Market Size & Forecast (2023-2030), By Diagnostic Method, USD Million

8.1.    Introduction

8.2.    Conventional Diagnostics

8.3.    Automated Diagnostics

9.      Global Sepsis Diagnostics Market Size & Forecast (2023-2030), By Test Type, USD Million

9.1.    Introduction

9.2.    Laboratory Testing

9.3.    Point-of-Care Testing

10.   Global Sepsis Diagnostics Market Size & Forecast (2023-2030), By End User, USD Million

10.1. Introduction

10.2. Hospitals & Clinics

10.3. Diagnostic Laboratories

10.4. Others

11.   Global Sepsis Diagnostics Market Size & Forecast (2023-2030), By Region, USD Million

11.1. Introduction

11.2. North America Sepsis Diagnostics Market Size & Forecast (2023-2030), By Country, USD Million

11.2.1.      US

11.2.1.1.      Market Size & Forecast, By Product (USD Million)

11.2.1.2.      Market Size & Forecast, By Technology (USD Million)

11.2.1.3.      Market Size & Forecast, By Pathogen Type (USD Million)

11.2.1.4.      Market Size & Forecast, By Diagnostic Method (USD Million)

11.2.1.5.      Market Size & Forecast, By Test Type (USD Million)

11.2.1.6.      Market Size & Forecast, By End User (USD Million)

11.2.2.     Canada

11.2.2.1.      Market Size & Forecast, By Product (USD Million)

11.2.2.2.      Market Size & Forecast, By Technology (USD Million)

11.2.2.3.      Market Size & Forecast, By Pathogen Type (USD Million)

11.2.2.4.      Market Size & Forecast, By Diagnostic Method (USD Million)

11.2.2.5.      Market Size & Forecast, By Test Type (USD Million)

11.2.2.6.      Market Size & Forecast, By End User (USD Million)

11.3. Europe Sepsis Diagnostics Market Size & Forecast (2023-2030), By Country, USD Million

11.3.1.     UK

11.3.1.1.      Market Size & Forecast, By Product (USD Million)

11.3.1.2.      Market Size & Forecast, By Technology (USD Million)

11.3.1.3.      Market Size & Forecast, By Pathogen Type (USD Million)

11.3.1.4.      Market Size & Forecast, By Diagnostic Method (USD Million)

11.3.1.5.      Market Size & Forecast, By Test Type (USD Million)

11.3.1.6.      Market Size & Forecast, By End User (USD Million)

11.3.2.     Germany

11.3.2.1.      Market Size & Forecast, By Product (USD Million)

11.3.2.2.      Market Size & Forecast, By Technology (USD Million)

11.3.2.3.      Market Size & Forecast, By Pathogen Type (USD Million)

11.3.2.4.      Market Size & Forecast, By Diagnostic Method (USD Million)

11.3.2.5.      Market Size & Forecast, By Test Type (USD Million)

11.3.2.6.      Market Size & Forecast, By End User (USD Million)

11.3.3.     France

11.3.3.1.      Market Size & Forecast, By Product (USD Million)

11.3.3.2.      Market Size & Forecast, By Technology (USD Million)

11.3.3.3.      Market Size & Forecast, By Pathogen Type (USD Million)

11.3.3.4.      Market Size & Forecast, By Diagnostic Method (USD Million)

11.3.3.5.      Market Size & Forecast, By Test Type (USD Million)

11.3.3.6.      Market Size & Forecast, By End User (USD Million)

11.3.4.     Italy

11.3.4.1.      Market Size & Forecast, By Product (USD Million)

11.3.4.2.      Market Size & Forecast, By Technology (USD Million)

11.3.4.3.      Market Size & Forecast, By Pathogen Type (USD Million)

11.3.4.4.      Market Size & Forecast, By Diagnostic Method (USD Million)

11.3.4.5.      Market Size & Forecast, By Test Type (USD Million)

11.3.4.6.      Market Size & Forecast, By End User (USD Million)

11.3.5.     Spain

11.3.5.1.      Market Size & Forecast, By Product (USD Million)

11.3.5.2.      Market Size & Forecast, By Technology (USD Million)

11.3.5.3.      Market Size & Forecast, By Pathogen Type (USD Million)

11.3.5.4.      Market Size & Forecast, By Diagnostic Method (USD Million)

11.3.5.5.      Market Size & Forecast, By Test Type (USD Million)

11.3.5.6.      Market Size & Forecast, By End User (USD Million)

11.3.6.     Rest of Europe

11.3.6.1.      Market Size & Forecast, By Product (USD Million)

11.3.6.2.      Market Size & Forecast, By Technology (USD Million)

11.3.6.3.      Market Size & Forecast, By Pathogen Type (USD Million)

11.3.6.4.      Market Size & Forecast, By Diagnostic Method (USD Million)

11.3.6.5.      Market Size & Forecast, By Test Type (USD Million)

11.3.6.6.      Market Size & Forecast, By End User (USD Million)

11.4. Asia Pacific (APAC) Sepsis Diagnostics Market Size & Forecast (2023-2030), By Country, USD Million

11.4.1.     China

11.4.1.1.      Market Size & Forecast, By Product (USD Million)

11.4.1.2.      Market Size & Forecast, By Technology (USD Million)

11.4.1.3.      Market Size & Forecast, By Pathogen Type (USD Million)

11.4.1.4.      Market Size & Forecast, By Diagnostic Method (USD Million)

11.4.1.5.      Market Size & Forecast, By Test Type (USD Million)

11.4.1.6.      Market Size & Forecast, By End User (USD Million)

11.4.2.     Japan

11.4.2.1.      Market Size & Forecast, By Product (USD Million)

11.4.2.2.      Market Size & Forecast, By Technology (USD Million)

11.4.2.3.      Market Size & Forecast, By Pathogen Type (USD Million)

11.4.2.4.      Market Size & Forecast, By Diagnostic Method (USD Million)

11.4.2.5.      Market Size & Forecast, By Test Type (USD Million)

11.4.2.6.      Market Size & Forecast, By End User (USD Million)

11.4.3.     India

11.4.3.1.      Market Size & Forecast, By Product (USD Million)

11.4.3.2.      Market Size & Forecast, By Technology (USD Million)

11.4.3.3.      Market Size & Forecast, By Pathogen Type (USD Million)

11.4.3.4.      Market Size & Forecast, By Diagnostic Method (USD Million)

11.4.3.5.      Market Size & Forecast, By Test Type (USD Million)

11.4.3.6.      Market Size & Forecast, By End User (USD Million)

11.4.4.     Rest of Asia Pacific

11.4.4.1.      Market Size & Forecast, By Product (USD Million)

11.4.4.2.      Market Size & Forecast, By Technology (USD Million)

11.4.4.3.      Market Size & Forecast, By Pathogen Type (USD Million)

11.4.4.4.      Market Size & Forecast, By Diagnostic Method (USD Million)

11.4.4.5.      Market Size & Forecast, By Test Type (USD Million)

11.4.4.6.      Market Size & Forecast, By End User (USD Million)

11.5. Latin America (LATAM) Sepsis Diagnostics Market Size & Forecast (2023-2030), USD Million

11.5.1.     Market Size & Forecast, By Product (USD Million)

11.5.2.     Market Size & Forecast, By Technology (USD Million)

11.5.3.     Market Size & Forecast, By Pathogen Type (USD Million)

11.5.4.     Market Size & Forecast, By Diagnostic Method (USD Million)

11.5.5.     Market Size & Forecast, By Test Type (USD Million)

11.5.6.     Market Size & Forecast, By End User (USD Million)

11.6. Middle East & Africa (MEA) Sepsis Diagnostics Market Size & Forecast (2023-2030), USD Million

11.6.1.     Market Size & Forecast, By Product (USD Million)

11.6.2.     Market Size & Forecast, By Technology (USD Million)

11.6.3.     Market Size & Forecast, By Pathogen Type (USD Million)

11.6.4.     Market Size & Forecast, By Diagnostic Method (USD Million)

11.6.5.     Market Size & Forecast, By Test Type (USD Million)

11.6.6.     Market Size & Forecast, By End User (USD Million)

12.   Competitive Landscape

12.1. Key Players and their Competitive Positioning

12.1.1.     Key Player Comparison

12.1.2.     Segment-wise Player Mapping

12.1.3.     Market Share Analysis (2024)

12.1.4.     Company Categorization Matrix

12.1.4.1.      Dominants/Leaders

12.1.4.2.      New Entrants

12.1.4.3.      Emerging Players

12.1.4.4.      Innovative Players

12.2. Key Strategies Assessment, By Player (2022-2025)

12.2.1.     New Product Launches

12.2.2.     Partnerships, Agreements, & Collaborations

12.2.3.     Mergers & Acquisitions

12.2.4.     Geographic Expansion

13.   Company Profiles*

(Business Overview, Financial Performance**, Products Offered, Recent Developments)

13.1. Biomérieux

13.2. Becton, Dickinson & Company (BD)

13.3. Danaher Corporation

13.4. F. Hoffmann-La Roche Ltd 

13.5. Thermo Fisher Scientific Inc.

13.6. Bruker

13.7. Abbott Laboratories

13.8. Siemens Healthineers

13.9. Qiagen

13.10.                DiaSorin S.p.A.

13.11.                Text Box: Note: *Indicative list
**For listed companies

Other Prominent Players


Note: *Indicative list

**For listed companies